Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Simbol: 002693.SZ
SHZ
5.69
CNYPrețul de piață astăzi
-39.5632
Raportul P/E
2.2749
Raportul PEG
2.36B
MRK Cap
- 0.00%
Randament DIV
Hainan Shuangcheng Pharmaceuticals Co., Ltd. (002693-SZ) Situații financiare
Bilanț
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 31.9 | 146 | 77 | |||||||||||||||
balance-sheet.row.short-term-investments | 0 | 28.5 | 133.8 | 55.4 | |||||||||||||||
balance-sheet.row.net-receivables | 0 | 16.4 | 41 | 33.1 | |||||||||||||||
balance-sheet.row.inventory | 0 | 74.3 | 65.4 | 55.2 | |||||||||||||||
balance-sheet.row.other-current-assets | 0 | 0.2 | 0 | 0.1 | |||||||||||||||
balance-sheet.row.total-current-assets | 0 | 135.2 | 252.4 | 165.4 | |||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 457.6 | 471.8 | 504.7 | |||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.intangible-assets | 0 | 171.8 | 164.9 | 156.9 | |||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 171.8 | 164.9 | 156.9 | |||||||||||||||
balance-sheet.row.long-term-investments | 0 | 10 | 8.8 | 17.3 | |||||||||||||||
balance-sheet.row.tax-assets | 0 | 1.5 | 1 | 1 | |||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 27.1 | 12.2 | 9.1 | |||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 668 | 658.6 | 689.1 | |||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-assets | 0 | 803.2 | 911 | 854.6 | |||||||||||||||
balance-sheet.row.account-payables | 0 | 17.1 | 15.5 | 17.2 | |||||||||||||||
balance-sheet.row.short-term-debt | 0 | 10.1 | 205.3 | 0.3 | |||||||||||||||
balance-sheet.row.tax-payables | 0 | 3.7 | 12.8 | 7.2 | |||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 135 | 0 | 167 | |||||||||||||||
Deferred Revenue Non Current | 0 | 8 | 7.6 | 8.9 | |||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||
balance-sheet.row.other-current-liab | 0 | 2 | 73.6 | 1.8 | |||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 145.7 | 10.7 | 179.4 | |||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-liab | 0 | 285.6 | 330.1 | 287.8 | |||||||||||||||
balance-sheet.row.preferred-stock | 0 | 34.4 | 0 | 0 | |||||||||||||||
balance-sheet.row.common-stock | 0 | 416.7 | 414.7 | 412 | |||||||||||||||
balance-sheet.row.retained-earnings | 0 | -347 | -296.2 | -305.2 | |||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -0.4 | 87.2 | 82.2 | |||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 367.6 | 307.9 | 292.9 | |||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 471.5 | 513.5 | 481.8 | |||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 803.2 | 911 | 854.6 | |||||||||||||||
balance-sheet.row.minority-interest | 0 | 46.2 | 67.4 | 84.9 | |||||||||||||||
balance-sheet.row.total-equity | 0 | 517.6 | 580.9 | 566.8 | |||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||
Total Investments | 0 | 10 | 133.8 | 55.4 | |||||||||||||||
balance-sheet.row.total-debt | 0 | 145.1 | 205.3 | 167.3 | |||||||||||||||
balance-sheet.row.net-debt | 0 | 141.7 | 193.1 | 145.6 |
Situația fluxurilor de numerar
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -8.5 | -40.8 | -79.9 | ||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 57.5 | 54.3 | 57.1 | ||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -0.4 | 0.4 | 1.2 | ||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 6.9 | 7.2 | -1.2 | ||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -4.5 | 14.9 | -12.2 | ||||||||||||||
cash-flows.row.account-receivables | 0 | -13.8 | 5.4 | 39.8 | ||||||||||||||
cash-flows.row.inventory | 0 | -9.9 | -4.8 | -4.3 | ||||||||||||||
cash-flows.row.account-payables | 0 | 19.6 | 13.8 | -48.9 | ||||||||||||||
cash-flows.row.other-working-capital | 0 | -0.4 | 0.4 | 1.2 | ||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -25.8 | -12.5 | 24.5 | ||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -33 | -31.6 | -51.6 | ||||||||||||||
cash-flows.row.acquisitions-net | 0 | 27 | 21.7 | 53.6 | ||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -471 | -256.2 | -637.2 | ||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 391.9 | 299.2 | 615.3 | ||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | -51.6 | ||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -85.1 | 33 | -71.5 | ||||||||||||||
cash-flows.row.debt-repayment | 0 | -12 | -55.3 | -1.8 | ||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.dividends-paid | 0 | -11.1 | -9.1 | -9.8 | ||||||||||||||
cash-flows.row.other-financing-activites | 0 | 68.1 | 23.8 | 57 | ||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 44.9 | -40.6 | 45.4 | ||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0.1 | -0.1 | -0.3 | ||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -14.8 | 15.8 | -36.9 | ||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 6.8 | 21.6 | 5.8 | ||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 21.6 | 5.8 | 42.7 | ||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 25.2 | 23.6 | -10.5 | ||||||||||||||
cash-flows.row.capital-expenditure | 0 | -33 | -31.6 | -51.6 | ||||||||||||||
cash-flows.row.free-cash-flow | 0 | -7.8 | -8.1 | -62.1 |
Rândul din contul de profit și pierdere
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 235.9 | 274.8 | 320.3 | |||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 74.9 | 88.3 | 81.4 | |||||||||||||||
income-statement-row.row.gross-profit | 0 | 161.1 | 186.5 | 238.9 | |||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||
income-statement-row.row.other-expenses | 0 | 0.2 | 63.2 | 69 | |||||||||||||||
income-statement-row.row.operating-expenses | 0 | 183.4 | 215.8 | 282.7 | |||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 258.3 | 304.1 | 364.1 | |||||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 0.1 | 0.1 | |||||||||||||||
income-statement-row.row.interest-expense | 0 | 9.6 | 11.2 | 9 | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -50.6 | 15.6 | 2 | |||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0.2 | 63.2 | 69 | |||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -50.6 | 15.6 | 2 | |||||||||||||||
income-statement-row.row.interest-expense | 0 | 9.6 | 11.2 | 9 | |||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 52.7 | 57.5 | 54.3 | |||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||
income-statement-row.row.operating-income | 0 | -73.2 | -24.5 | -42.3 | |||||||||||||||
income-statement-row.row.income-before-tax | 0 | -73 | -8.9 | -40.4 | |||||||||||||||
income-statement-row.row.income-tax-expense | 0 | -1 | -0.4 | 0.4 | |||||||||||||||
income-statement-row.row.net-income | 0 | -50.7 | -8.5 | -40.8 |
Întrebări frecvente
Ce este Hainan Shuangcheng Pharmaceuticals Co., Ltd. (002693.SZ) totalul activelor?
Hainan Shuangcheng Pharmaceuticals Co., Ltd. (002693.SZ) activele totale sunt 803248121.000.
Care este venitul anual al întreprinderii?
Venitul anual este N/A.
Care este marja de profit a întreprinderii?
Marja de profit a firmei este 0.654.
Care este fluxul de numerar liber al întreprinderii?
Fluxul de numerar liber este -0.103.
Care este marja de profit net a întreprinderii?
Marja profitului net este -0.324.
Care este venitul total al întreprinderii?
Venitul total este -0.443.
Care este Hainan Shuangcheng Pharmaceuticals Co., Ltd. (002693.SZ) profitul net (venitul net)?
Profitul net (venitul net) este -50741578.370.
Care este datoria totală a firmei?
Datoria totală este 145050750.000.
Care este numărul cheltuielilor de exploatare?
Cheltuielile de exploatare sunt 183423820.000.
Care este cifra de numerar a firmei?
Numerarul întreprinderii este 0.000.